Skip to content
A doctor discussing a lab report with a patient in a warm home setting

FDA Approves the First Oral PCSK9 Inhibitor

The US Food and Drug Administration has approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor. It is a daily tablet for adults with high LDL cholesterol, including an inherited form called heterozygous familial hypercholesterolaemia (HeFH). It is used alongside diet and exercise.

What changes with this approval?

PCSK9 is a protein involved in how the liver clears LDL cholesterol from the blood. Blocking it helps lower LDL. Lipfendra offers an oral option for this treatment target.

What did the studies show?

The FDA reviewed two trials involving 3,207 adults. Participants were already taking the highest statin dose they could tolerate and needed further LDL reduction.

At 24 weeks, the LDL reduction compared with placebo was about 56% in one trial and 59% in the trial for adults with HeFH. These are study averages. Individual results can differ.

What should patients know about safety?

The prescribing information reports similar overall rates of adverse reactions between treatment and placebo in the larger study. Diarrhoea and dizziness occurred more often with Lipfendra in the HeFH study.

A doctor must review your health history, medicines and treatment needs. This article does not provide a dosing plan. Follow the instructions from your prescriber and the approved medicine information.

Does lower LDL prove fewer heart attacks?

Lower LDL and fewer cardiovascular events are different outcomes. The label describes evidence for event reduction with statins and injectable antibody PCSK9 medicines. Do not assume those results establish the same benefit for Lipfendra itself.

What does this mean for people in Dubai?

The announcement concerns US approval. It does not establish UAE approval or local availability. Check with a licensed clinician and the relevant local authority before seeking treatment.

If you are concerned about cholesterol, discuss your results and current treatment with your doctor. Do not stop or change a prescribed medicine on the basis of a news report.

MyCare can help coordinate a doctor consultation or a request for blood tests at home, subject to review and availability.

Sources

This information is for general education and does not replace medical advice.

Your cart

Your cart is currently empty.

Not sure where to start?
Try these collections: